Profile
FCA Health Innovations is a venture capital firm based in Nashville, Tennessee, founded over 15 years ago. The firm is backed by six North Carolina health systems and a major payor, providing executive advisory access and a digital-health playbook to navigate provider/payor channels. FCA focuses on healthcare investments, leveraging its deep domain expertise and valuable network in sectors such as providers, payers, pharma, and innovative care delivery.
The firm invests primarily in the healthcare sector, with a focus on digital health, SaaS, data, AI, and fintech. FCA typically invests in Series A rounds with an average check size of $2-4 million. The firm has raised $335 million in capital and has strategic partnerships with 12 entities. FCA Health Innovations Fund II, a venture capital fund, was launched in 2020 and is closed, with investments in companies like Posterity Health and Credo Health.
Notable investments by FCA include Posterity Health - clinics/outpatient services, Nmible - business/productivity software, Credo Health - medical records systems, Carallel - healthcare technology systems, Peregrine Health - clinics/outpatient services, and Javara - clinics/outpatient services.
Industry
Fca Health Innovations Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
FCA Health Innovations Fund II
|
Venture Capital (VC)
|
Healthcare Services
|
North America
|
$1-5 m
|
—
|
January 2020
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.